Company Search:
Advanced Search
Sponsored Links
Cansino Biologics Inc Company Snapshot
Cansino Biologics Inc operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Cansino Biologics Inc with three other pharmaceutical manufacturers in Asia: Ensol Biosciences Inc of KOREA (SOUTH) (2018 sales of 399.89 million Korean Won [US$336,310.15 ] of which 100% was Pharmaceutical Development and Sales), Cho Pharma Inc of TAIWAN (290,000.00 Taiwanese Dollars [US$9,851.30 ] ), and Syncore Biotechnology Co Ltd which is also based in TAIWAN (7.71 million Taiwanese Dollars [US$261,772.82 ] ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Cansino Biologics Inc
  Stock Performance Chart for Cansino Biologics Inc
  Stock Data: Recent Stock Performance:
  Current Price (8/7/2020): 241.00
(Figures in Hong Kong Dollars)
1 Week -11.2%   13 Weeks 6.9%  
4 Weeks 50.9%   52 Weeks 657.9%  
Cansino Biologics Inc Key Data:
  Ticker: 6185 Country: China
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2018 Sales 1,340,073
(Year Ending Jan 2019).
Employees: 429
  Currency: Hong Kong Dollars Market Cap: 53,658,625,659
  Fiscal Yr Ends: December Shares Outstanding: 222,649,899
  Share Type: Ordinary Closely Held Shares: 124,577,399
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.